Discovery Drug Metabolism News
Two weeks left and two opportunities left to meet scientist to scientist, face to face at your lab or office, with Phytronix, the inventors of the Laser Diode Thermal Desorption (LDTD) ion source.
OK, this may not be the conventional way to learn about a technology that speeds analysis in 10 seconds or less. But then again, drug discovery may require unconventional means to overcome its biggest challenges.
If you agree, you’re not alone:
A just-published study by AstraZeneca (Macclesfield, UK) using dry blood spots (DBS) and the LDTD concludes: “The use of LDTD reduces analytical run times due to its inherently rapid nature … and the technique has great potential within the phamaceutical industry not only for in vivo analysis but also for use as a rapid sample introduction technique for in vitro experiments such as absorption and solubility assays which often screen many hundreds of compounds per week”.
Now you have choices. You can learn more, the conventional, safe way:
* Watch the video at LDTD Video
* Peruse articles from Journal of Pharmaceutical and Biomedical Analysis at Pharmaceutical publications
* Read a data sheet at LDTD Data sheet
Or take the unconventional approach:
For those in the New Jersey or Philadelphia area, take this time, today, to secure one of the 2 remaining spots available on May 4 and 5 to meet with Phytronix and get your answers to the vexing problems in your small compound drug discovery –
Contact me, Richard Halpern at email@example.com, or call 617.364.7683.
Sometimes when you look at a problem from a different angle, the answers become obvious.